Variables
Combined procedure (n=117)
Male, n (%) 64 (54.7)
Age, years 67 [57, 75]
BMI, kg/m2 20.1±10.6
LVEF, % 59 [39, 60]
OAC therapy, n (%) 39 (33.3)
AF type
Paroxysmal AF, n (%)
58 (49.6)
Short-term persistent AF, n (%)
20 (17.1)
Long-term persistent AF, n (%)
39 (33.3)
CHA2DS2-VASc score 3 [2, 5]
Congestive heart failure, n (%)
26 (22.2)
Hypertension, n (%)
85 (72.6)
Age
≥75, n (%) 36 (30.8)
65-75, n (%) 46 (39.3)
Diabetes mellitus, n (%)
31 (26.5)
Stroke/TIA, n (%)
49 (41.9)
Vascular disease, n (%)
19 (16.2)
HAS-BLED score 2 [1, 3]
Abnormal liver function, n (%)
0
Abnormal renal function, n (%)
6 (5.1)
Bleeding, n (%)
13 (11.1)
Labile INR, n (%)
8 (6.8)
Drug use, n (%)
38 (32.5)
Alcohol abuse, n (%)
9 (7.7)